Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Doyeon Oh"'
Autor:
Hye Won Park1, Doyeon Oh1, Namkeun Kim1, Hee Yeon Cho2, Kyung Chul Moon3, Jong Hee Chae2, Hyo Seop Ahn2, Yong Choi2, Hae Il Cheong2 cheonghi@snu.ac.kr
Publikováno v:
Pediatric Nephrology. Sep2008, Vol. 23 Issue 9, p1555-1558. 4p. 2 Color Photographs, 3 Black and White Photographs.
Publikováno v:
Clinical Nephrology. 75:165-170
Thrombotic microangiopathy (TMA) is a rare renal complication accompanied with Castleman's disease. We report the first case of TMA combined plasma cell type multicentric Castleman's disease (MCD) which was successfully treated with rituximab and cor
Autor:
Hyo Seop Ahn, Yong Choi, Hae Il Cheong, Doyeon Oh, Nam Keun Kim, Kyung Chul Moon, Jong Hee Chae, Hye Won Park, Hee Yeon Cho
Publikováno v:
Pediatric Nephrology. 23:1555-1558
Thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy disorder associated with congenital or acquired deficiency of the von Willebrand factor-cleaving protease, ADAMTS13. The central nervous system and kidneys are the two major or
Autor:
And Sang-Do Lee, Yeon-Mok Oh, Eunkyung Kim, Seon-Ju Lee, Doyeon Oh, Yong-Wook Cho, Seong-Gyu Hwang, Ji Hyun Lee, Hye-Cheol Jeong
Publikováno v:
The Tohoku journal of experimental medicine. 227(4)
Chronic obstructive pulmonary disease (COPD) is classified into emphysema and chronic bronchitis, which are thought to result from different pathophysiological pathways. Smoking-induced lung parenchymal destruction and inadequate repair are involved
Autor:
Hau C. Kwaan, Sun Ju Lee, Jeehyeon Bae, So Young Chong, Ji Young Huh, Moon Ju Jang, Doyeon Oh, Kwang-Hoe Chung
Publikováno v:
Blood. 118:4306-4306
Abstract 4306 Arsenic trioxide (As2O3; ATO) has been established to be an effective agent for treating acute promyelocytic leukemia (APL). Tetra-arsenic oxide (As4O6; TAO) is a new arsenic compound which has shown anti-proliferative and apoptosis-ind
Autor:
Yeung-Chul Mun, Jin Seok Ahn, Won Sik Lee, Se Hoon Park, Deog-Yeon Jo, Jong Jin Seo, Hyuk Chan Kwon, Myung-Ju Ahn, Kyung Hee Lee, Myung Soo Hyun, Jae-Hoon Lee, Byoung Kook Kim, Yeon Hee Park, Hun-Mo Ryoo, Hyo-Jin Kim, So Young Chong, Moon Hee Lee, Bongseog Kim, Seung-Hyun Nam, Jung-Hye Choi, Sung-Soo Yoon, Hyung Nam Moon, Kyung Tae Park, Inho Kim, Young Joo Min, Chul Soo Kim, Dae Young Zang, Sung-Hyun Kim, Chu-Myong Seong, Seonyang Park, Young-Don Joo, Doyeon Oh, Thad T. Ghim, Hwi-Joong Yoon, Hawk Kim, Sung Hwa Bae, Eun Kyoung Cho, Jae Hoo Park, Soo-Mee Bang, Hong Suk Song, Heung Sik Kim
Publikováno v:
Blood. 112:2975-2975
Cytogenetics is still being considered the most powerful single prognostic factor, which is useful to determine the types of post-remission therapy in AML, though various molecular markers are available for predicting the prognosis of AML patients. M
Publikováno v:
Proceedings of the American Thoracic Society. 3:545-545
Bone marrow–derived circulating endothelial progenitor cells (cEPCs) are considered to have a key role in the maintenance of vascular integrity and to act as “repair cells” in response to endothelial injury. Some current studies have suggested
Autor:
Myung Seo Kang, Jin Young Baek, Moon Ju Jang, Doyeon Oh, Sei Kyung Chang, So Young Chong, Young Kil Choi
Publikováno v:
The Korean Journal of Hematology. 41:208
The outcome after unrelated cord blood transplantation (CBT) is similar to that of matched unrelated bone marrow transplantation in children, and the results of CBT in adult patients has recently shown improvement. In addition, the use of reduced-int
Publikováno v:
The Korean Journal of Hematology. 41:215
Mantle cell lymphoma is a subtype of aggressive non-Hodgkin's lymphoma and usually presents in advanced stages. When treated with a regimen such as CHOP, the median survival is about three years. More aggressive front-line therapy with the hyper-CVAD